lorazepam and moclobemide

lorazepam has been researched along with moclobemide in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	4 (57.14)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Grahnén, A; Jansson, B; Küppers, H; Simpson, PM; Weimann, HJ; Wesnes, K	1
De Angelis, L; Furlan, C	1

Trials

1 trial(s) available for lorazepam and moclobemide

Article	Year
Moxonidine and cognitive function: interactions with moclobemide and lorazepam. European journal of clinical pharmacology, 1997, Volume: 52, Issue:5 Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents; Antihypertensive Agents; Attention; Benzamides; Cognition; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Imidazoles; Lorazepam; Male; Middle Aged; Moclobemide	1997

Article

Year

Moxonidine and cognitive function: interactions with moclobemide and lorazepam.

European journal of clinical pharmacology, 1997, Volume: 52, Issue:5

Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents; Antihypertensive Agents; Attention; Benzamides; Cognition; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Imidazoles; Lorazepam; Male; Middle Aged; Moclobemide

1997

Other Studies

6 other study(ies) available for lorazepam and moclobemide

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test. Pharmacology, biochemistry, and behavior, 2000, Volume: 65, Issue:4 Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Convulsants; Darkness; Drug Interactions; Female; Light; Lorazepam; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Pentylenetetrazole; Selegiline	2000